Essbio S.A. reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported sales was CLP 49,745.3 million compared to CLP 43,339.69 million a year ago. Net loss was CLP 2,917.9 million compared to net income of CLP 2,879.63 million a year ago. Basic loss per share from continuing operations was CLP 0.11 compared to basic earnings per share from continuing operations of CLP 0.11 a year ago.
For the six months, sales was CLP 109,277.99 million compared to CLP 94,315.44 million a year ago. Net income was CLP 8,756.93 million compared to CLP 12,753.36 million a year ago. Basic earnings per share from continuing operations was CLP 0.33 compared to CLP 0.49 a year ago.